Navigation Links
Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting
Date:10/7/2008

ase is a strict gluten-free diet; however, the response to therapy is poor or incomplete in up to 30 percent of patients. These facts suggest that there is a need for therapeutic modalities beyond dietary modification.

Related data presented in a third poster at ACG include results from a qualitative study conducted to investigate the validity of the Gastrointestinal Symptom Rating Scale (GSRS) in patients with celiac disease. The GSRS is a validated measure used in clinical trials for irritable bowel syndrome and peptic ulcer disease. GSRS has been utilized in studies to assess larazotide acetate, including CLIN 1001-004 and CLIN 1001-006. Results from the poster presentation suggest that certain subscales of the GSRS may have relevance for use in establishing the efficacy of novel treatments for celiac disease. This is the first time the validity of the GSRS clinical scale has been studied in celiac disease to assess efficacy of treatments.

"There are currently no products approved by the FDA to treat celiac disease and a clear need exists for a therapeutic option," said Daniel Leffler, MD, gastroenterologist, Beth Israel Deaconess Medical Center and one of the lead investigators for CLIN 1001-004. "This study showed that larazotide acetate prevented immunologic changes induced by gluten in patients with celiac disease. In addition, studies to establish the validity of scales such as GSRS are an important step forward in the development of effective treatments for celiac disease."

"Alba is excited to be advancing the first therapy for celiac disease and we are encouraged by these breakthrough findings," said Dr. Francisco Leon, head of Clinical Research and Development at Alba Therapeutics, Inc. "These results will be further tested in Phase III clinical trials to evaluate safety, efficacy, and maintenance of effect of larazotide acetate in treating celiac disease. In addition, we are excited by early preclinical study results showing signs of
'/>"/>

SOURCE Alba Therapeutics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. In Vivo Data on Taligen Therapeutics Pipeline Candidates Presented at the XXII International Complement Workshop
2. BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
3. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
4. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
5. PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy
6. Data from In Vivo Disease Models on Taligen Therapeutics Pipeline Candidates to be Presented at the XXII International Complement Workshop
7. Data Confirm Synvista Therapeutics Haptoglobin Diagnostic Test Kit Success in Rapidly Determining Cardiovascular Risk in Patients with Diabetes
8. Logical Therapeutics Inc. Commences Double-Blind, Randomized Study of Their Lead Program, LT-NS001
9. Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch
10. Tobira Therapeutics Inc. Receives US Patent for TBR-652
11. MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... KONG, Nov. 28, 2014 HK$,000Six months endedChange %  30 September ... Cord Blood Storage Service Income , 384,242 , ... , 61,878 , 41,377 , 49.5 ... 2,249 , 6.4 Medical Devices and Accessories Sales ... Chinese Herbal Medicines Sales , 2,917 , 9,219 ...
(Date:11/26/2014)...  Thoratec Corporation (NASDAQ: THOR ), a ... save, support and restore failing hearts, said today it ... On Tuesday, December 2, the company will participate ... Conference.  D. Keith Grossman , President and Chief ... beginning at 11:30 a.m., Eastern Standard Time (8:30 a.m., ...
(Date:11/26/2014)... -- Cohen, Placitella & Roth, PC is investigating potential ... Pharmaceutical Corporation ("Nymox" or "Company") (NASDAQ: ... 2011 through November 2, 2014 ("Class Period").  The ... officers and directors publically disseminated materially false and/or ... 20(a) of the Securities Exchange Act of 1934 ...
Breaking Medicine Technology:Golden Meditech Announces 2014 / 2015 Interim Results 2Golden Meditech Announces 2014 / 2015 Interim Results 3Golden Meditech Announces 2014 / 2015 Interim Results 4Golden Meditech Announces 2014 / 2015 Interim Results 5Golden Meditech Announces 2014 / 2015 Interim Results 6Golden Meditech Announces 2014 / 2015 Interim Results 7Golden Meditech Announces 2014 / 2015 Interim Results 8Thoratec Announces Presentations At Investor Conferences For December 2014 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3
... COLUMBIA, Md., Nov. 11, 2010 Celsion Corporation ... drug development company, today announced that the Committee ... Medicines Agency (EMA) has issued a positive opinion ... ThermoDox®, a proprietary heat-activated liposomal encapsulation of doxorubicin, ...
... Arbor Pharmaceuticals, a specialty pharmaceutical company based in Atlanta, ... financing.  This financing included a $17.5 million investment in ... Signet Healthcare Partners, LLC.  The remainder of the financing ... by several of the investing parties.  Also participating in ...
Cached Medicine Technology:Celsion Receives COMP Recommendation for Orphan Drug Designation in Europe for ThermoDox® to Treat Primary Liver Cancer 2Celsion Receives COMP Recommendation for Orphan Drug Designation in Europe for ThermoDox® to Treat Primary Liver Cancer 3Celsion Receives COMP Recommendation for Orphan Drug Designation in Europe for ThermoDox® to Treat Primary Liver Cancer 4Arbor Pharmaceuticals Completes $34.8 Million Financing 2Arbor Pharmaceuticals Completes $34.8 Million Financing 3
(Date:11/28/2014)... 2014 Mirena lawsuits ( http://www.mirenalawsuit2014.com/ ... New Jersey’s Bergen County Superior Court, where the ... there is quickly approaching 1,300, Bernstein Liebhard LLP ... shows 1,293 lawsuits now pending in the consolidated ... complications resulting from spontaneous migration of the birth ...
(Date:11/28/2014)... Walder, one of South Florida’s top cosmetic dermatologists , ... that is designed to help her patients reduce unwanted fat ... has been praised by patients as being permanent, painless, and ... types of external fat reduction. , “If you can pinch ... According to Dr. Walder, Ultrashape works by targeting subcutaneous fat, ...
(Date:11/28/2014)... Texas (PRWEB) November 28, 2014 Dr. Paul Vitenas, ... will hold a Glitter & Glow Holiday Event for those in ... treatments offered at his practice. Glitter & Glow will take place ... Dr. Vitenas’ new location in the heart of Houston at 4208 ... of holidays and hope that you will come and celebrate the ...
(Date:11/28/2014)... 28, 2014 Secura Consultants, based ... insurance marketing organizations in the country focused on ... protection marketplace. Secura Consultants is proud to offer ... Financial Group, a leading global financial company. , ... With the ownership interest comes the need for ...
(Date:11/28/2014)... Celebration can quickly turn to tragedy if popular turkey ... Over the last decade, more than 141 serious fires ... turkey fryers, according to the U.S. Consumer Product Safety ... who tried to deep fry the turkey indoors, which ... Arthur Sanford, a burn surgeon at Loyola University Health ...
Breaking Medicine News(10 mins):Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 2Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 3Health News:Dr. Diane Walder Introduces New Fat Reduction Treatment Called Ultrashape 2Health News:Dr. Diane Walder Introduces New Fat Reduction Treatment Called Ultrashape 3Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 3Health News:Secura Consultants Offers Complimentary Buy-Sell Agreement Reviews 2Health News:Turkey Fryer Mishaps Can Cause Serious Burns 2
... MONDAY, May 23 (HealthDay News) -- Women who gained 18 or ... three times more likely to develop gestational diabetes during their second ... the study, published in the May 23 online issue of ... to shed six or more pounds between babies cut their risk ...
... primary care specialty of internal medicine has identified common clinical ... care and better use of finite clinical resources. ... activities appears online in the Archives of Internal Medicine ... list of best practices via consensus from actual practitioners, said ...
... 23 (HealthDay News) -- Researchers report that they,ve discovered a ... a finding that might provide insight into how the germ ... About 200 million people around the world are thought ... chronically infected people in the United States. Many don,t know ...
... , NEW YORK, May 23, 2011More than eight of ... believe states should be allowed to implement key provisions ... support, ahead of the timeline outlined in the law. ... more low-income families and creating insurance exchanges with premium ...
... , MONDAY, May 23 (HealthDay News) -- Undercover research ... to provide emergency care to children with private insurance ... Posing as mothers of a fictional 10-year-old boy ... 85 dental practices twice, four weeks apart, to determine ...
... is a reasonably safe and accurate method for the initial ... April issue of the Journal of the American College ... shave biopsies for not providing accurate T (tumor) stage information, ... to determine the impact of shave biopsies on the initial ...
Cached Medicine News:Health News:Losing Baby Weight Cuts Odds of Pregnancy-Linked Diabetes 2Health News:'Top 5' list helps primary care doctors make wiser clinical decisions 2Health News:'Top 5' list helps primary care doctors make wiser clinical decisions 3Health News:Researchers Find Cousin of Hepatitis C Virus in Dogs 2Health News:States should be allowed to implement key health reform law provisions early, experts say 2Health News:States should be allowed to implement key health reform law provisions early, experts say 3Health News:Some Dentists Reluctant to Treat Kids on Medicaid: Study 2Health News:Some Dentists Reluctant to Treat Kids on Medicaid: Study 3Health News:Shave biopsy is a safe and acceptable method for initial evaluation of melanoma 2
1000 L, Bulk Recommended for 500 and 1000 L pipettes....
Inquire...
... way to order tips. Each box contains 1000 ... which contains 200 tips (4 bags of 50 ... of 200 tips per pack. Bulk Packs are ... be opened for quick access to Gilsons Diamond ...
... Finntips have been designed to optimize the ... of our tip products is widely recognized ... range has been extended over the years ... standard and special tips including filter tips, ...
Medicine Products: